ANN LUNDY: Open Payments
NPI 1588021497 · CRYSTAL RIVER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 16 payments from 8 companies in 2025. Trend: 2023 $637 · 2024 $316 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Lilly USA, LLC | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| PFIZER INC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
Products named: JARDIANCE, TRELEGY ELLIPTA, REPATHA, MOUNJARO, Ozempic, OTEZLA, PREVNAR 20, FARXIGA.
Industry payments across FL — which companies pay providers there.
